Bayer CropScience navigates a complex agricultural landscape defined by climate volatility and shifting demand for corn, balancing its long-term strategic growth framework against recent regulatory headwinds. Investors will be closely watching the company's margin trajectory following its Q3 profit recovery and the status of recent tax penalty appeals.
| Results date | May 26, 2026 |
|---|---|
| Quarter | Q4 FY 2025-2026 |
| Previous quarter revenue | Rs. 11,062 Million |
| Previous quarter PAT | Rs. 1,130 Million (PBT) |
| Previous quarter EBITDA margin | 13.2% (FY2024-25 Operating Profit Margin) |
| Market cap | Rs. 19,394.76 Cr |
| CMP | Rs. 4315.5 |
The board meeting is scheduled for May 26, 2026, to approve the audited financial results for the quarter and financial year ended March 31, 2026, and consider the final dividend recommendation for FY 2025-26.
In its most recently reported quarter, Bayer CropScience posted revenue of Rs. 11,062 Million, PBT of Rs. 1,130 Million, and an EBITDA margin of 13.2%. Management is focused on sustaining the growth momentum seen in the corn segment, which maintained its number one market position for the third consecutive year in 2024. The company continues to execute its five-year strategic framework, which targets over 3.5 billion Euro in incremental net sales and over 1.0 billion Euro in margin improvements by 2029. Additionally, the upcoming results will provide clarity on the impact of three recent regulatory penalty orders totaling Rs. 41.86 Million and the company's preparedness for the Kharif FY2026 season.
Margin and Profitability Trajectory: Monitoring the recovery from the 460 bps decline in operating profit margin observed in FY2024-25.
Regulatory and Compliance Status: Updates on the resolution of recent tax-related penalty orders.
Corn and Strategic Growth Drivers: Evaluating the performance of core segments and long-term strategic initiatives.
Bayer CropScience is scheduled to announce its Q4 FY 2025-2026 results on May 26, 2026.
The board meeting on May 26, 2026, includes an agenda item to consider a final dividend recommendation for FY 2025-26.
Bayer CropScience reported revenue from operations of Rs. 11,062 Million for the quarter ended December 31, 2025.
The company received three penalty orders totaling Rs. 41.86 Million between March and April 2026. Management has stated these orders are appealable and is currently assessing the decision to exercise its right to appeal.
The corn business is driven by operational excellence, commercial activation, and ecosystem partnerships in the silage and ethanol sectors. Management is also prioritizing portfolio acceleration and investment in new geographies to maintain market leadership.
Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings
Login Now